Factors that affect life expectancy of patients with gastric adenocarcinoma

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background & Aims: We used a new, semi-parametric method to estimate life expectancy and expected years of lifelost (EYLL) after diagnosis of gastric cancer and assess whether patients' sex or tumor type or location had any effects. Methods: We performed a nationwide retrospective cohort study of 35,576 patients with gastric cancer who were registered in the Taiwan Cancer Registry from 1998 through 2007; data were collected until the end of 2010. The Monte Carlo method and tables in Taiwan National Vital Statistics database were matched to the cohort reference populations onthe basis of age and sex. The estimated regression line and the survival curve of reference populations were used to extrapolate the survival curve beyond 2010. We compared patients' age at diagnosis, life expectancy, and EYLL based on sex, tumor type, and location. Results: In Taiwan, gastric cancer is more prevalent among men, and 88.6% of tumors are adenocarcinomas. Patients with adenocarcinoma of the gastric cardia have shorter life expectancies and greater EYLL than those with noncardia tumors (P < .05). Women with gastric adenocarcinoma are diagnosed at a younger age and have longer life expectancies but more EYLL than men with such tumors (P < .05). The estimated years of life saved if gastric adenocarcinoma is diagnosed at an early stage and cured are 22,827 years (2.62 years/case) for women and 33,700 years (1.97 years/case) for men. Conclusion: Among patients with gastric cancer, men and patients with adenocarcinomas of the cardia have shorter life expectancies and more EYLL. Early detection of gastric adenocarcinoma canincrease life expectancy.

Original languageEnglish
Pages (from-to)1595-1600
Number of pages6
JournalClinical Gastroenterology and Hepatology
Volume11
Issue number12
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Life Expectancy
Stomach
Adenocarcinoma
Stomach Neoplasms
Taiwan
Neoplasms
Cardia
Monte Carlo Method
Vital Statistics
Survival
Population
Registries
Cohort Studies
Retrospective Studies
Databases

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

@article{1e70680795b1423aa8534e67bc08eb02,
title = "Factors that affect life expectancy of patients with gastric adenocarcinoma",
abstract = "Background & Aims: We used a new, semi-parametric method to estimate life expectancy and expected years of lifelost (EYLL) after diagnosis of gastric cancer and assess whether patients' sex or tumor type or location had any effects. Methods: We performed a nationwide retrospective cohort study of 35,576 patients with gastric cancer who were registered in the Taiwan Cancer Registry from 1998 through 2007; data were collected until the end of 2010. The Monte Carlo method and tables in Taiwan National Vital Statistics database were matched to the cohort reference populations onthe basis of age and sex. The estimated regression line and the survival curve of reference populations were used to extrapolate the survival curve beyond 2010. We compared patients' age at diagnosis, life expectancy, and EYLL based on sex, tumor type, and location. Results: In Taiwan, gastric cancer is more prevalent among men, and 88.6{\%} of tumors are adenocarcinomas. Patients with adenocarcinoma of the gastric cardia have shorter life expectancies and greater EYLL than those with noncardia tumors (P < .05). Women with gastric adenocarcinoma are diagnosed at a younger age and have longer life expectancies but more EYLL than men with such tumors (P < .05). The estimated years of life saved if gastric adenocarcinoma is diagnosed at an early stage and cured are 22,827 years (2.62 years/case) for women and 33,700 years (1.97 years/case) for men. Conclusion: Among patients with gastric cancer, men and patients with adenocarcinomas of the cardia have shorter life expectancies and more EYLL. Early detection of gastric adenocarcinoma canincrease life expectancy.",
author = "Wei-Yiing Chen and Hsiu-Chi Cheng and Jung-Der Wang and Bor-Shyang Sheu",
year = "2013",
month = "12",
day = "1",
doi = "10.1016/j.cgh.2013.05.036",
language = "English",
volume = "11",
pages = "1595--1600",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Factors that affect life expectancy of patients with gastric adenocarcinoma

AU - Chen, Wei-Yiing

AU - Cheng, Hsiu-Chi

AU - Wang, Jung-Der

AU - Sheu, Bor-Shyang

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Background & Aims: We used a new, semi-parametric method to estimate life expectancy and expected years of lifelost (EYLL) after diagnosis of gastric cancer and assess whether patients' sex or tumor type or location had any effects. Methods: We performed a nationwide retrospective cohort study of 35,576 patients with gastric cancer who were registered in the Taiwan Cancer Registry from 1998 through 2007; data were collected until the end of 2010. The Monte Carlo method and tables in Taiwan National Vital Statistics database were matched to the cohort reference populations onthe basis of age and sex. The estimated regression line and the survival curve of reference populations were used to extrapolate the survival curve beyond 2010. We compared patients' age at diagnosis, life expectancy, and EYLL based on sex, tumor type, and location. Results: In Taiwan, gastric cancer is more prevalent among men, and 88.6% of tumors are adenocarcinomas. Patients with adenocarcinoma of the gastric cardia have shorter life expectancies and greater EYLL than those with noncardia tumors (P < .05). Women with gastric adenocarcinoma are diagnosed at a younger age and have longer life expectancies but more EYLL than men with such tumors (P < .05). The estimated years of life saved if gastric adenocarcinoma is diagnosed at an early stage and cured are 22,827 years (2.62 years/case) for women and 33,700 years (1.97 years/case) for men. Conclusion: Among patients with gastric cancer, men and patients with adenocarcinomas of the cardia have shorter life expectancies and more EYLL. Early detection of gastric adenocarcinoma canincrease life expectancy.

AB - Background & Aims: We used a new, semi-parametric method to estimate life expectancy and expected years of lifelost (EYLL) after diagnosis of gastric cancer and assess whether patients' sex or tumor type or location had any effects. Methods: We performed a nationwide retrospective cohort study of 35,576 patients with gastric cancer who were registered in the Taiwan Cancer Registry from 1998 through 2007; data were collected until the end of 2010. The Monte Carlo method and tables in Taiwan National Vital Statistics database were matched to the cohort reference populations onthe basis of age and sex. The estimated regression line and the survival curve of reference populations were used to extrapolate the survival curve beyond 2010. We compared patients' age at diagnosis, life expectancy, and EYLL based on sex, tumor type, and location. Results: In Taiwan, gastric cancer is more prevalent among men, and 88.6% of tumors are adenocarcinomas. Patients with adenocarcinoma of the gastric cardia have shorter life expectancies and greater EYLL than those with noncardia tumors (P < .05). Women with gastric adenocarcinoma are diagnosed at a younger age and have longer life expectancies but more EYLL than men with such tumors (P < .05). The estimated years of life saved if gastric adenocarcinoma is diagnosed at an early stage and cured are 22,827 years (2.62 years/case) for women and 33,700 years (1.97 years/case) for men. Conclusion: Among patients with gastric cancer, men and patients with adenocarcinomas of the cardia have shorter life expectancies and more EYLL. Early detection of gastric adenocarcinoma canincrease life expectancy.

UR - http://www.scopus.com/inward/record.url?scp=84887989227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887989227&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2013.05.036

DO - 10.1016/j.cgh.2013.05.036

M3 - Article

C2 - 23811250

AN - SCOPUS:84887989227

VL - 11

SP - 1595

EP - 1600

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 12

ER -